Test Code BIOTN Biotin, Serum
Ordering Guidance
If testing for biotinidase deficiency is requested, order BIOTS / Biotinidase, Serum.
Shipping Instructions
Freeze specimens within 3 days of collection and send frozen.
Specimen Required
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.
Useful For
Measurement of biotin in serum
Assessment of biotin concentrations in individuals taking biotin supplements
Investigation of unexpected results from immunoassays that utilize biotin-streptavidin detection methods
This test is not useful as a screen for biotinidase deficiency.
Method Name
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Reporting Name
Biotin, SSpecimen Type
SerumSpecimen Minimum Volume
0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Frozen (preferred) | 30 days | |
Refrigerated | 7 days | ||
Ambient | 24 hours |
Reject Due To
Gross hemolysis | OK |
Gross lipemia | OK |
Gross icterus | OK |
Clinical Information
Biotin is a water soluble B complex vitamin (vitamin B7 or vitamin H) that is an essential cofactor for the synthesis of fatty acids, catabolism of branched chained amino acids, and for gluconeogenesis. It is usually found at relatively low endogenous concentrations in patients on a normal diet. However, biotin can be found in over-the-counter multi-vitamins, prenatal vitamins, and dietary supplements marketed for hair, skin, and nail growth. Additionally, treatment of certain progressive multiple sclerosis patients with high doses of biotin has been reported to be beneficial. Biotin supplementation from either over-the-counter or prescription sources can result in extremely elevated circulating biotin. Some immunoassays in the clinical laboratory use chemistry that utilizes the high affinity and avidity that biotin has for binding avidin (or streptavidin). As a result, high serum biotin concentrations can yield inaccurate laboratory results in laboratory assays that utilize this biotin-streptavidin chemistry. Specifically, specimens with high biotin can yield falsely decreased results when the testing methodology utilizes sandwich-based methods or falsely increased results when the methodology utilizes competitive binding methods. Each clinical laboratory method that utilizes biotin-streptavidin chemistry has a defined biotin concentration limit above which serum biotin can interfere with assay results. This test measures free biotin concentrations in serum and can be used to determine whether a patient has high biotin concentrations that are likely from biotin supplementation/treatment.
Reference Values
≥18 years: ≤0.3 ng/mL
Reference values have not been established for patients who are <18 years of age.
Interpretation
Biotin results that are significantly higher than the reference interval indicate biotin supplementation.
Cautions
It is unknown how long biotin will remain elevated in patients taking biotin supplements. Variables include the dose taken, the duration of supplementation, and the time of blood draw after ingestion.
Supportive Data
An internal study of volunteers taking 1 dose of 5000 to 20,000 micrograms of biotin showed elevated serum biotin concentrations of between 10 to 50 ng/mL at 1 to 2 hours post supplementation.
Method Description
Biotin (Vitamin B7) is quantified in serum by liquid chromatography tandem mass spectrometry.(Unpublished Mayo method)
Specimen Retention Time
7 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterCPT Code Information
84591
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
BIOTN | Biotin, S | 1980-2 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
606867 | Biotin, S | 1980-2 |
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.Day(s) Performed
Tuesday